myopia
Conditions
Interventions
None listed
Sponsors
Santen Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Parents with children of elementary or junior high school student living with them as of April 2024. Parents who can check the results of the visual acuity test of the child in the 2024 school health examination and can answer the uncorrected visual acuity of both eyes
Exclusion criteria
Exclusion criteria: Medical professionals (doctors, pharmacists, nurses, etc.) Subjects engaged in pharmaceuticals, medical devices industry, eyeglasses, and contact lenses manufacturing industries Subjects engaged in pharmaceuticals distributor or eyeglasses/contact lenses distributor business. Subjects engaged in information provision services, research services, and advertising Parents of the children in the survey who have eye diseases affecting vision other than myopia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The anxiety caused by children's myopia and the impact of children's myopia on the quality of life of parents with children in elementary and junior high school The parents' understanding and desire for myopia The actual status of treatment in children with myopia | — |
Countries
Japan
Contacts
Public ContactEtsuyo Miyamoto
Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group
Outcome results
None listed